Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
We report the effect of GDNF-secreting ECB device, which allows constitutive secretion of glial cell neurotrophic factor (GDNF). These devices were provided by NsGENE, which is our collaborative company. Our result of ELISA assay indicate that GDNF continued secreting it from those devices for 12 months, and it was revealed that we could maintain those devices. We found that maintenance medium that was derived from those devices raised cell viability of odontblast like cell (KN-3 cell) under 0.1% serum. These data suggest that GDNF-secreting ECB device are available to maintain odontblast viability and proliferation.
|